Synapse
⌘+K
Synapse
PulseExploreClubsResearchersJournals
Instagram
HomeClubsExplore
April 10, 2019New England Journal of Medicine

Pembrolizumab Treatment for Progressive Multifocal Leukoencephalopathy

View Full Paper
Ask AI
Bookmark
Share

Authors

ICIrene CorteseNational Institute of Neurological Disorders and StrokePMPawel MuranskiNewYork–Presbyterian HospitalYEYoshimi Enose‐AkahataNational Institutes of Health

Discussion

Loading...

Member takes

Implication

Key Points

Key points are not available for this paper at this time.

Cite This Study

Cortese et al. (2019) studied this question.

synapsesocial.com/papers/69dbecf9d60f0b8828835bd2https://doi.org/10.1056/nejmoa1815039
View Full Paper
Ask AI
Bookmark
Share

Also Consider

Synapse has enriched 5 closely related papers on similar clinical questions. Consider them for comparative context:

  1. 1Immunophenotypic characterization of CSF B cells in virus-associated neuroinflammatory diseases2018 · 38 citations
  2. 2Immune checkpoint inhibitors: recent progress and potential biomarkers2018 · 2,147 citations
  3. 3A study of mefloquine treatment for progressive multifocal leukoencephalopathy: results and exploration of predictors of PML outcomes2013 · 166 citations
  4. 4Failure of Cytarabine in Progressive Multifocal Leukoencephalopathy Associated with Human Immunodeficiency Virus Infection1998 · 348 citations
  5. 5A pilot study of cidofovir for progressive multifocal leukoencephalopathy in AIDS2002 · 207 citations